The association of HPV infection and vaginal microbiota of reproductive women in China: A multicenter cohort study protocol

Small, 2017, Cervical cancer: a global health crisis, Cancer, 123, 2404, 10.1002/cncr.30667 Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA A Cancer J Clin, 68, 394, 10.3322/caac.21492 Muñoz, 2004, Against which human papillomavirus types shall we vaccinate and screen? The international perspective, Int J Cancer, 111, 278, 10.1002/ijc.20244 de Martel, 2012, Global burden of cancers attributable to infections in 2008: a review and synthetic analysis, Lancet Oncol, 13, 607, 10.1016/S1470-2045(12)70137-7 Crosbie, 2013, Human papillomavirus and cervical cancer, Lancet (London, England), 382, 889, 10.1016/S0140-6736(13)60022-7 Moscicki, 2005, Human papilloma virus, papanicolaou smears, and the college female, Pediatr Clin, 52, 163 Plummer, 2007, A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion, JID (J Infect Dis), 195, 1582, 10.1086/516784 Barton, 1988, Effect of cigarette smoking on cervical epithelial immunity: a mechanism for neoplastic change?, Lancet (London, England), 2, 652, 10.1016/S0140-6736(88)90469-2 Sugawara, 2019, Cigarette smoking and cervical cancer risk: an evaluation based on a systematic review and meta-analysis among Japanese women, Jpn J Clin Oncol, 49, 77, 10.1093/jjco/hyy158 Remoue, 2003, High intraepithelial expression of estrogen and progesterone receptors in the transformation zone of the uterine cervix, Am J Obstet Gynecol, 189, 1660, 10.1016/S0002-9378(03)00852-4 Appleby, 2007, Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies, Lancet (London, England), 370, 1609, 10.1016/S0140-6736(07)61684-5 Jensen, 2013, Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up, Br J Cancer, 108, 234, 10.1038/bjc.2012.513 Muñoz, 2002, Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study, Lancet (London, England), 359, 1093, 10.1016/S0140-6736(02)08151-5 Burk, 1996, Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors, Sex Transm Dis, 23, 333, 10.1097/00007435-199607000-00013 Zhang, 2020, Cervical cancer: epidemiology, risk factors and screening, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu, 32, 720, 10.21147/j.issn.1000-9604.2020.06.05 Smith, 2002, Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer, J Natl Cancer Inst, 94, 1604, 10.1093/jnci/94.21.1604 Ji, 2019, The burden of human papillomavirus and Chlamydia trachomatis coinfection in women: a large cohort study in inner Mongolia, China, JID (J Infect Dis), 219, 206, 10.1093/infdis/jiy497 Guo, 2012, Bacterial vaginosis is conducive to the persistence of HPV infection, Int J STD AIDS, 23, 581, 10.1258/ijsa.2012.011342 Brusselaers, 2019, Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis, BJOG An Int J Obstet Gynaecol, 221, 9 Chen, 2019, Association between the vaginal microbiome and high-risk human papillomavirus infection in pregnant Chinese women, BMC Infect Dis, 19, 677, 10.1186/s12879-019-4279-6 Ma, 2014, Human papillomavirus community in healthy persons, defined by metagenomics analysis of human microbiome project shotgun sequencing data sets, J Virol, 88, 4786, 10.1128/JVI.00093-14 Huang, 2018, Cervicovaginal microbiota composition correlates with the acquisition of high-risk human papillomavirus types, Int J Cancer, 143, 621, 10.1002/ijc.31342 Di Paola, 2017, Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection Brotman, 2014, Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection, JID (J Infect Dis), 210, 1723, 10.1093/infdis/jiu330 Chaban, 2014, Characterization of the vaginal microbiota of healthy Canadian women through the menstrual cycle, Microbiome, 2, 23, 10.1186/2049-2618-2-23 Roy, 1962, The concentration of oestrogens in blood during pregnancy, J Obstet Gynaecol Br Emp, 69, 13, 10.1111/j.1471-0528.1962.tb00002.x DiGiulio, 2015, Temporal and spatial variation of the human microbiota during pregnancy Ferrer, 2017, Antibiotic use and microbiome function, Biochem Pharmacol, 134, 114, 10.1016/j.bcp.2016.09.007 Hoffman, 2017, Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): a systematic review, Int J Cancer, 141, 8, 10.1002/ijc.30623 Liao, 2020, Multi-infection patterns and Co-infection preference of 27 human papillomavirus types among 137,943 gynecological outpatients across China, Front Oncol, 10, 449, 10.3389/fonc.2020.00449 Wang, 2015, Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China, BMC Infect Dis, 15, 257, 10.1186/s12879-015-0998-5 Ribeiro, 2020, Human papillomavirus and Chlamydia trachomatis infections in adolescents and young women: prevalence and risk factors, Diagn Cytopathol, 48, 736, 10.1002/dc.24460 Liu Oh, 2015, The association of uterine cervical microbiota with an increased risk for cervical intraepithelial neoplasia in Korea, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 21, 10.1016/j.cmi.2015.02.026 Mitra, 2020, The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions Mitra, 2015, Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity, Sci Rep, 5, 10.1038/srep16865 Kyrgiou, 2017, Does the vaginal microbiota play a role in the development of cervical cancer?, Transl Res, 179, 168, 10.1016/j.trsl.2016.07.004 Chao, 2019, Correlation between the diversity of vaginal microbiota and the risk of high-risk human papillomavirus infection, Int J Gynecol Cancer : official journal of the International Gynecological Cancer Society, 29, 28, 10.1136/ijgc-2018-000032 Lee, 2013, Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort, PLoS One, 8, 10.1371/journal.pone.0063514 Gao, 2013, Comparison of the vaginal microbiota diversity of women with and without human papillomavirus infection: a cross-sectional study, BMC Infect Dis, 13, 271, 10.1186/1471-2334-13-271 Onywera, 2019, The cervical microbiota in reproductive-age South African women with and without human papillomavirus infection, Papillomavirus Research, 7, 154, 10.1016/j.pvr.2019.04.006 Mitra, 2016, The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next?, Microbiome, 4, 58, 10.1186/s40168-016-0203-0 Mortaki, 2019, Vaginal microbiota and human papillomavirus: a systematic review, J Turk Ger Gynecol Assoc Schiffman, 2007, Human papillomavirus and cervical cancer, Lancet (London, England), 370, 890, 10.1016/S0140-6736(07)61416-0 Macklaim, 2015, Changes in vaginal microbiota following antimicrobial and probiotic therapy, Microb Ecol Health Dis, 26 Han, 2021, Does probiotics work for bacterial vaginosis and vulvovaginal candidiasis, Curr Opin Pharmacol, 61, 83, 10.1016/j.coph.2021.09.004